ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma.

Transl Androl Urol · 2023 · PMC10170270 · PMID 37181232

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Furthermore, the results showed a decreasing trend of ALDOB expression with an upgrade of T stage, M stage, AJCC stage, and histologic grade of ccRCC patients ( Figure 6 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.